recast-jats-buildd8e1462159jitcJ Immunother CancerjitcJournal for ImmunoTherapy of CancerJ Immunother CancerJ Immunother Cancer2051-1426BMJ Publishing Group Ltdjitc-2020-0779-6corr110.1136/jitc-2020-0779-6corr1/jitc/8/2/e0779-6corr1.atomCorrectionOpen accessSpecial collectionsOpen accessCorrection: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis 7202016720202962020296202082e0779-6corr1© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.2020https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.special-featureunlocked

Xing P, Zhang F, Wang G, et al. Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis. J ImmunoTher Cancer 2019;7:341. doi: 10.1186/s40425-019-0779-6

In the article titled ‘Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis’, the author noticed that the second corresponding author was not designated in the article.

The correct corresponding authors are:

Junling Li - Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 17 Pan-jia-yuan South Lane, Chaoyang District, 100021, Beijing, China. Email: lijunling@cicams.ac.cn

Yan Wang - Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 17 Pan-jia-yuan South Lane, Chaoyang District, 100021, Beijing, China. Email: wangyanyifu@126.com